|
시장보고서
상품코드
2050940
관상동맥 스텐트 시장 : 제품 유형별, 소재별, 최종사용자별, 지역별Coronary Stents Market, By Product Type, By Material, By End User, By Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
관상동맥 스텐트 시장은 2026년에 150억 7,860만 달러로 추정되고, 2033년까지 260억 6,060만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.1%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 150억 7,860만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.10% | 2033년 시장 규모 예측 : | 260억 6,060만 달러 |
관상동맥 스텐트(CS)는 기저질환인 죽상동맥경화증으로 인해 동맥이 막혔을 때 관상동맥 내에 삽입하는 확장 가능한 관 모양의 금속 장치입니다. 이 혈행재건술은 경피적 관상동맥중재술(PCI) 또는 스텐트 삽입을 동반한 관상동맥성형술이라고 합니다.
관상동맥 스텐트는 1980년대에 처음 개발되었으며, 모양, 구조 및 사용되는 재료의 측면에서 계속 진화하고 있습니다.
시장 역학
규제 당국의 제품 승인 증가는 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 12월, 관상동맥 스텐트 치료의 접근법을 재정의하는 비상장 기업인 Svelte Medical은 관상동맥 협착 환자를 위한 'SLENDER 실로리무스 용출형 관상동맥 스텐트 통합 전달 시스템'과 'DIRECT 실로리무스 용출형 관상동맥 스텐트 신속 교환 전달 시스템'에 대한 미국 식품의약국(FDA)의 승인을 받았다고 발표했습니다. 관상동맥 스텐트 래피드 익스체인지 딜리버리 시스템'에 대해 미국 식품의약국(FDA)의 승인을 획득했다고 발표했습니다.
관상동맥 질환의 유병률 증가는 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 10월 미국 질병예방통제센터(CDC)가 발표한 기사에 따르면 심장병은 미국 내 사망원인 1위이며, 미국 20세 이상 성인 중 약 2,010만 명이 관상동맥질환(CAD)을 앓고 있는 것으로 나타났습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 세계 관상동맥 스텐트 시장의 주요 기업 프로파일을 소개합니다.
- 이 보고서를 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 관상동맥 스텐트 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 관상동맥 스텐트 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 관상동맥 스텐트 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 관상동맥 스텐트 시장 : 소재별, 2021년-2033년
제6장 세계의 관상동맥 스텐트 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 관상동맥 스텐트 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.06.15Coronary Stents Market is estimated to be valued at USD 15,078.6 Mn in 2026 and is expected to reach USD 26,060.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 15,078.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.10% | 2033 Value Projection: | USD 26,060.6 Mn |
Coronary stents (CS) are expandable tubular metallic devices, which are introduced into coronary arteries, when the arteries are clogged due to an underlying atherosclerosis disease. This revascularization procedure is termed as a percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement.
The coronary stent was first developed in the 1980s, and has continued to evolve in terms of shape, structure, and the material used within them.
Market Dynamics
Increasing product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, in December 2022, Svelte Medical, which is a privately-held company, dedicated to redefining the approach to coronary stenting, announced the U.S. Food and Drug Administration (FDA) approval for SLENDER Sirolimus-Eluting Coronary Stent Integrated Delivery System and DIRECT Sirolimus-Eluting Coronary Stent Rapid Exchange Delivery System, which is intended for use in patients who have a narrowing in their coronary arteries.
The increasing prevalence of coronary heart diseases is expected to drive the market growth over the forecast period. For instance, in October 2022, according to an article published by Centers for Disease Control and Prevention (CDC), stated that heart disease is the leading cause of death in the U.S. and about 20.1 million adults age 20 and older in the U.S. have Coronary Artery Disease (CAD).
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global coronary stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study Medtronic, iVascular, Alvimedica, Alta Biomaterials, Japan Medical Device Technology Co., Ltd., Veritas Bioventions Pvt Ltd, Nano Therapeutics Pvt. Ltd, Abbott, SLTL Group, Translumina Therapeutics LLP, DSM, Arterius, Terumo Corporation, SMT, Boston Scientific Corporation, Cook, Biotronik, B. Braun SE, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd, C. R. Bard, Inc, KYOTO MEDICAL PLANNING Co., Ltd, QualiMed, Elixir Medical Corporation, ENDOCOR GmbH & CO. KG, Amaranth Medical, Inc.
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global coronary stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary stents market.
Market Segmentation
- Global Coronary Stents Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Bare-Metal Stents
- Drug Eluting Stents
- Bioabsorbable Stents
- Global Coronary Stents Market, By Material (Revenue, USD Mn, 2021 - 2033)
- Metallic
- Stainless Steel
- Silicon Carbide
- Titanium Nitride Oxide
- Cobalt Chromium
- Platinum Chromium
- Others
- Polymeric
- Non-degradable/Permanent Stents
- Degradable/Temporary Stents
- Global Coronary Stents Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- Global Coronary Stents Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- iVascular
- Alvimedica
- Alta Biomaterials
- Japan Medical Device Technology Co., Ltd.
- Veritas Bioventions Pvt Ltd.
- Nano Therapeutics Pvt. Ltd.
- Abbott
- SLTL Group
- Translumina Therapeutics LLP
- DSM
- Arterius
- Terumo Corporation
- SMT
- Boston Scientific Corporation
- Cook
- KYOTO MEDICAL PLANNING Co., Ltd.
- QualiMed
- Elixir Medical Corporation
- ENDOCOR GmbH & CO. KG
- Amaranth Medical, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Material
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Material Landscape
- PORTER's Analysis
- Pricing Analysis (2022)
4. Global Coronary Stents Market, By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Bare-Metal Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Drug Eluting Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Bioabsorbable Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Coronary Stents Market, By Material, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Metallic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Stainless Steel
- Silicon Carbide
- Titanium Nitride Oxide
- Cobalt Chromium
- Platinum Chromium
- Others
- Polymeric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Non-degradable/Permanent Stents
- Degradable/Temporary Stents
6. Global Coronary Stents Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Coronary Stents Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- iVascular
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alvimedica
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alta Biomaterials
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Japan Medical Device Technology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Veritas Bioventions Pvt Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nano Therapeutics Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SLTL Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Translumina Therapeutics LLP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- DSM
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Arterius
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SMT
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cook
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biotronik
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B. Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Meril Life Sciences Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- C. R. Bard, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- KYOTO MEDICAL PLANNING Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QualiMed
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Elixir Medical Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ENDOCOR GmbH & CO. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amaranth Medical, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
